Mereo BioPharma raises $119 mln
Mereo BioPharma Group Ltd. said Wednesday that it raised $119 million from Woodford Investment Management and Invesco Perpetual. Mereo also acquired a portfolio of three clinical-stage development programmes from Novartis Pharmaceuticals, which will also hold an equity stake in Mereo. London-based Mereo is a recently-formed speciality biopharmaceutical company.
29 July 2015•10 mins read
